The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 141-146

  Tsioufis, Costas ^a,d   Thomopoulos, Konstantinos ^a   Dimitriadis, Kyriakos ^a   Amfilochiou, Anastasia ^c   Tousoulis, Dimitris ^b   Alchanatis, Manos ^b   Stefanadis, Christodoulos ^b   Kallikazaros, Ioannis ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Arterial stiffness; Hypertension; Obstructive sleep apnoea; Pulse wave velocity; Risk factors

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PULSE WAVE; RESPIRATORY TRACT PARAMETERS; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

EID: 33845351680     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32801092c1     Document Type: Article

References (40)

1. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al., for the Sleep Heart Health Study. Association of sleep disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283:1829-1836.
2. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384.
3. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003; 289:2560-2572.
4. Kraiczi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000; 89:493-498.
5. Weber T, Auer J, O'Rourke M, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections and the risk of coronary artery disease. Circulation 2004; 109:184-199.
6. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end organ renal disease. Circulation 1999; 99:2434-2439.
7. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
8. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all cause cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
9. The Report of an American Academy of Sleep Medicine Task Force. Sleep related breathing disorders in adults. Sleep 1999; 22:667-689.
10. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1153.
11. Garcia-Rio F, Racionero M, Pino J, Martinez I, Ortuno F, Villasante C, Villamor J. Sleep apnea and hypertension. Chest 2000; 117:1417-1425.
12. Whitney CW, Gottlieb DJ, Redline S, Norman RG, Dodge RR, Shahar E, et al. Reliability of scoring respiratory disturbance indexes and sleep staging. Sleep 1998; 21:749-757.
13. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84:I280-I287.
14. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al. American Society of Echocardiography Committee on Standards. Subcommittee on Quantication of Two-dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
15. Asmar R, Topouchian J, Crisan O, Pannier B, Rudnichi A, Safar M. Reversion of arterial abnormalities by long term antihypertensive therapy in a large population. The Complior study. J Hypertens 1999; 17 (Suppl. 3):S9-S10.
16. Tsioufis C, Chatzis D, Dimitriadis K, Stougianos P, Kakavas A, Vlasseros I, et al. Left ventricular diastolic dysfunction is accompanied by increased aortic stiffness in the early stages of essential hypertension: a TDI approach. J Hypertens 2005; 23:1745-1750.
17. Asmar R, Benetos A, Topouchian J, Lareunt P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertension 1995; 26:485-490.
18. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-2889.
19. Tsioufis C, Tzioumis C, Marinakis N, Toutouzas K, Tousoulis D, Kallikazaros I, et al. Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clin Pract 2003; 93:c106-c111.
20. Oliver JJ, Webb DJ. Non-invasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23:554-566.
21. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiffness increases during obstructive sleep apneas. Sleep 2002; 25:850-855.
22. Somers VK, Dyken ME, Clary MP, Abbound FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
23. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103:1763-1768.
24. Parati G, Di Rienzo M, Bonsignore MR, Insalaco G, Marrone O, Castiglioni P, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15:1621-1626.
25. Narkiewitz K, Pesek CA, Kato M, Phillips BG, Davison BE, Somers VK. Baroreflex control of sympathetic activity and heart rate in obstructive sleep apnea. Hypertension 1998; 32:1039-1043.
26. Tsioufis C, Thomopoulos C, Taxiarxou E, Toutouzas K, Tsiamis E, Kallikazaros I, et al. Carotid sinus stimulation responses are related with arterial elastic properties in hypertensive subjects. Am J Hypertens 2003; 16:914-918.
27. Kato M, Roberts, Thompson P, Phillips BG, Haynes WG, Winnicki M, et al. Impairment of endothelium-dependent vasodilatation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102:2607-2610.
28. Dean CT, Wilcox I. Possible atherogenic effect of hypoxia during obstructive sleep apnea. Sleep 1993; 16 (8 Suppl.):S15-S21.
29. Duchna HW, Guilleninault C, Stoohs A, Faul JL, Moreno H, Hoffman BB, Blasche TF. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000; 161:187-191.
30. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105:2462-2464.
31. Thomopoulos K, Tsioufis C, Anadiotis T, Vasileiadou K, Dimitriadis K, Amfilochiou A, et al. Obstructive sleep apnea is associated with increased levels of inflammatory markers in untreated newly diagnosed essential hypertensive subjects. Circulation 2004; 110:S2044.
32. Jurkovicova I, Celek P, Mucska I, Hoolosy J. On the origin of cardiovascular complications of sleep apnea syndrome by means of molecular interactions. Bratisl Lek Listy 2003; 104:167-173.
33. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999; 34:309-314.
34. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002; 92:627-633.
35. Miliauskas S, Sakalauskas R. Peculiarities of nocturnal oxygen saturation in obstructive sleep apnea. Medicina (Kaunas) 2005; 41:217-220.
36. Sharma SK, Kurian S, Malik V, Mohan A, Banga A, Pandey RM, et al. A stepped approach for prediction of obstructive sleep apnea in overtly asymptomatic obese subjects: a hospital based study. Sleep Med 2004; 5:351-357.
37. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al., the VALUE Trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031.
38. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003; 41:183.
39. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154:2219-2224.
40. The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.